KCNC2 and Parkinson disease: Increased excitability, and hence exacerbated excitotoxicity, may also derive from the reduced expression of ATP1A3, KCNC2, and SLC12A5. Mutations of the plasma-membrane Na+/K+ pump ATP1A3 have been linked to rapid-onset dystonia-parkinsonism [27].